MGH Pharmacy Residency PGY2 - Emergency Medicine

Overview

The ASHP-Accredited PGY2 EM Pharmacy Residency at MGH began in 2017. Residents learn the skills to establish an area of specialty in emergency medicine, critical care, infectious diseases, toxicology, trauma management, and education. Mass General offers a dynamic learning environment including a close partnership with the Harvard Affiliated Emergency Medicine Residency program (HAEMR) and the regional poison center. The resident plays an active role in clinical and administrative EM initiatives. Teaching experience is provided through the Department of Pharmacy and EM conferences/symposia, didactic teaching in the HAEMR program, pharmacy student and resident preceptorship. Finally, residents contribute to local and system-wide interdisciplinary committees pertaining to stroke care, sepsis management, emergency preparedness, and quality and safety.

We currently offer one position for the PGY2 EM Pharmacy Residency.

Program Goals

The resident will complete the following ASHP-established outcomes:

• Demonstrate leadership and practice management skills.
• Optimize the outcomes of EM patients by providing evidence-based medication therapy as an integral part of an interdisciplinary team.
• Demonstrate excellence in the provision of training, including preceptorship, or educational activities for health care professionals and health care professionals in training.
• Demonstrate the skills necessary to conduct an EM pharmacy research project.
• Develop an evidence-based approach when providing EM medication-related information.
• Participate in the management of medical emergencies.
• Describe the role of the poison center or medical toxicologist in the care of the toxicology patient.
• Demonstrate the ability to provide appropriate evidenced based recommendations for the patient in need of toxicologic intervention in the ED setting.

Learning Experiences

The first 2-4 weeks of residency is an orientation to the Department of Pharmacy, after a 2-day hospital orientation. Activities include competency lectures on basic clinical skills, training on the Mass General computerized order entry system, and side-by-side decentralized training with clinical pharmacy preceptors. Additionally, residents will understand the structure of the Residency Learning System, which is the backbone of how residency training is put into action.

Required Core Learning Experiences:

• Orientation (2-4 weeks)
• Emergency Medicine 1 (4-6 weeks)
• Emergency Medicine 2 (6 weeks; contains overnight experience)
• Emergency Medicine 3 (6 weeks)
• Medical ICU (4 weeks)
• Toxicology (4 weeks)
• Pediatric Critical Care/Emergency Medicine (4 weeks)
• Emergency Medicine Observation Unit (EDOU) (2 weeks)
• Emergency Medicine Precepting (4 weeks)

Elective Learning Experiences:

Total elective time is up to 14 weeks but may vary based on resident conference attendence time.

• Burn ICU (2-4 weeks)
• Cardiology ICU (4 weeks)
• Emergency Medicine Overnight (4 weeks)
• Infectious Diseases (2 weeks)
• Neurosciences ICU (2 weeks)
• Emergency Medicine Learning Experience (Boston Medical Center) (4 weeks)
• Psychiatry (2-4 weeks)
• Surgical ICU (4 weeks)

Longitudinal Experiences:

Required:

• Emergency Response (26 weeks)
• Emergency Medicine Pharmacist Forum (EMPF) (26 weeks; includes formal presentations, Medication Use Evaluation project, medication safety)
• Pharmacy Practice Experience (PPE) (52 weeks; ED decentralized clinical operations)
• Research Project (52 weeks)

Elective:

• Emergency Preparedness (52 weeks)

Other:

• Resident officer positions

Recruitment information

In the interest of accessibility and equity:

• Applicants who are interested in attending a virtual information session may sign up to attend the session (link will be available in the fall).
• In-person attendance at the showcase booth at the Midyear Clinical Meeting will not count towards the candidate’s application score.
• All interviews will be conducted virtually.

How to Apply

To be eligible to apply for the PGY2 Emergency Medicine Pharmacy Residency Program, applicants must be graduates of an ACPE-accredited school of pharmacy with a Doctor of Pharmacy (PharmD) degree and have completed or are in the process of completing an ASHP-accredited PGY1 residency program.

International applicants are welcome to apply to the PGY2 EM Pharmacy Residency if they are eligible to work in the U.S. and have an active visa (e.g. OPT) that expires after June of the following year during which the candidate is applying. International applicants will be considered based on the merits of their application. The MGH Department of Pharmacy is not able to sponsor H1B visas.

Applications must be submitted via PhORCAS and include the following to be complete:

• Formal letter of intent.
• Curriculum Vitae.
• Official pharmacy school transcript.
• Three standardized references completed through PhORCAS.
  • One should be from your PGY1 residency program director.

The deadline for receipt of a completed PhORCAS application is January 7th. Upon completion of applications review, qualified candidates will be contacted regarding interviews. The PGY2 Emergency Medicine Pharmacy Residency Program participates in the ASHP Resident Matching Program.

Contact Information

Lanting Fuh, PharmD, BCEMP, BCPS
Clinical Pharmacy Coordinator, Emergency Medicine
Director, PGY2 EM Pharmacy Residency
lfuh@mgh.harvard.edu